UNSPSC 51162029: Ephedrine/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162029 Ephedrine/theophylline is a Commodity code, but recent state and local procurement activity under this code shows little alignment with pharmaceutical active ingredients themselves. Instead, the opportunities posted reveal that state and local buyers are actually soliciting pharmacy services, naloxone procurement, generic pharmaceuticals distribution, and direct-to-manufacturer prescription programs — a much broader pharmacy and drug-supply category than the code's narrow name suggests. This mismatch indicates the code is being applied inconsistently or the opportunities have been tagged to a narrower ingredient code that does not reflect the actual scope of work being purchased. The issuing bodies include county government (Seminole County, Florida; Hall County, Georgia), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). Geographic activity spans Florida, Georgia, Texas, and Minnesota, with no clear concentration in any single region.

Recent opportunities illustrate the range of pharmacy-related work being tagged under this code. Seminole County, Florida posted an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (response deadline July 26, 2023), with quarterly deliveries to the Seminole County Community Health Building and eligibility for FEMA funding. Hall County, Georgia issued an RFQ/P #47-010 (due June 4, 2026) for on-site pharmacy services at the Hall County Government Family Health Center Clinic to serve 3,005 eligible individuals, with an 80/20 scoring structure favoring technical qualifications over cost and contract start January 1, 2027. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with awarded contracts effective July 1, 2026. The Texas Health and Human Services Commission issued an RFI (April 3, 2026) to gather vendor capabilities on a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. Bidders should recognize that this code shows sparse and misaligned recent activity; the opportunities reflect broader pharmacy procurement rather than ephedrine or theophylline specifically.